Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
- Publication date
- 1 January 2022
- Publisher
- 'Springer Science and Business Media LLC'